Geode Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-709,322
Closed -$11.2M 4693
2023
Q4
$11.2M Buy
709,322
+28,943
+4% +$279K ﹤0.01% 2278
2023
Q3
$5.27M Buy
680,379
+184,548
+37% +$1.53M ﹤0.01% 2609
2023
Q2
$4.92M Buy
495,831
+76,542
+18% +$613K ﹤0.01% 2680
2023
Q1
$2.43M Buy
419,289
+31,947
+8% +$276K ﹤0.01% 2948
2022
Q4
$3.08M Buy
387,342
+21,106
+6% +$90.6K ﹤0.01% 2891
2022
Q3
$1.16M Buy
366,236
+30,390
+9% +$190K ﹤0.01% 3321
2022
Q2
$1.92M Buy
335,846
+16,724
+5% +$130K ﹤0.01% 3126
2022
Q1
$2.25M Buy
319,122
+90,675
+40% +$1.43M ﹤0.01% 3208
2021
Q4
$5.23M Buy
228,447
+10,758
+5% +$278K ﹤0.01% 2874
2021
Q3
$6.44M Buy
+217,689
New +$7.38M ﹤0.01% 2765

Geode Capital Management's ICVX Position: Q1 2024 in Review

Geode Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 709,322 shares — an estimated $11.2M sold.

Geode Capital Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $11.2M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Geode Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 709,322 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $11.2M.
  • Geode Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Geode Capital Management's Icosavax, Inc. Common Stock position peaked at $11.2M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.